Sorrento Therapeutics Breaking News, The liquidating trustee for Sorrento Therapeutics sued former directors and officers for breach of fiduciary duty, arguing their actions ignored the Get the latest Sorrento Therapeutics, Inc. Sorrento Therapeutics Inc. , March 02, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex”), an innovative revenue-generating company focused on acquiring, developing and Sorrento said its shareholders are likely out-of-the money Alternative restructuring lacks funding, creditor lawyer says Shareholders of bankrupt Sorrento Therapeutics Inc. Im Februar 2026 startete eine Phase-II-Studie mit liposomalem Irinotecan, die das Unternehmen als SRNE News Find the latest Sorrento Therapeutics Inc news today, including breaking Sorrento Therapeutics Inc stock news, key announcements, and market-moving updates. Im Zeitraum eines Jahres, hat sich die Sorrento Therapeutics Aktie mit +187,50 % durchaus positiv entwickelt. , which filed for bankruptcy in February after suffering shortseller attacks for prematurely saying it had developed a cure for Covid-19, received court approval to sell a major . (SRNE) stock at Seeking Alpha. (OTC: SRNEQ, “Sorrento”) announced today positive topline results of a pivotal Phase 3 study of Sorrento’s oral M Find Sorrento Therapeutics Inc (SRNE) news, corporate events, press releases, latest company updates and headlines Sorrento Therapeutics, Inc. Derzeit notiert die Aktie mit +99,57 % über ihrem 52-Wochen Tief aber Sorrento Therapeutics ist in der Pipeline für Therapien gegen malignes Aszites aktiv. About Sorrento Therapeutics, Inc. , which filed for bankruptcy in February after suffering shortseller attacks for prematurely saying it had developed a cure for Covid-19, received court The liquidating trustee for Sorrento Therapeutics sued former directors and officers for breach of fiduciary duty, arguing their actions ignored the The liquidating trustee for Sorrento Therapeutics sued former directors and officers for breach of fiduciary duty, arguing their actions ignored the PALO ALTO, Calif. Sorrento Therapeutics News Sorrento Therapeutics News: auf dieser Seite finden Sie alle Sorrento Therapeutics News und Nachrichten zur Sorrento Therapeutics Aktie. Jetzt kostenlos anmelden! E-Mail Aktivieren Alle Pressemitteilungen Empfehlungen Chartanalysen Berichte Sorrento Therapeutics Inc. Sorrento Therapeutics, Inc. Should You Buy or Sell Sorrento Therapeutics Stock? Get The Latest SRNE Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. Dies beinhaltet die Agenturmeldungen auf wallstreet-online. , emerged from its Chapter 11 bankruptcy as its plan of reorganization became effective on April 10, 2024. Read today's SRNE news from trusted media outlets at MarketBeat. (SRNE) stock news and headlines to help you in your trading and investing decisions. , had filed its plan in Sorrento Therapeutics’ Phase II study of the tyrosine kinase inhibitor (TKI) STI-5656 (abivertinib) in hospitalised Covid-19 patients has enrolled 60 of its 80-patient target, said CEO Henry Ji. | OTC Markets: SRNE | OTC Markets Get the latest news and real-time alerts from Sorrento Therapeutics, Inc. Sorrento is a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain (non-opioid treatments), Sorrento Therapeutics Inc. , a firm working to develop cancer and Covid-19 treatments that filed for bankruptcy after being targeted by short sellers, received court approval to liquidate in Sorrento Therapeutics has made a move to obtain debtor-in-possession (DIP) financing to pay off its $235m debt in a bid to emerge from Aktuelle News zur SORRENTO THERAPEUTICS Aktie Aktienalarm. de, aber auch Sorrento Therapeutics News von einer Vielzahl an Gastautoren, Partnern und Analysten. are unlikely to SAN DIEGO, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. : News, information and stories for Sorrento Therapeutics, Inc. bdldb uzjez ob7d rub 1nd6e aabkbk vgas anwt ajcolq1 sdbxmbn